RxSight, Inc.
RXSTNasdaqCIK 1111485HealthcareFiscal year ends Dec 31
Reports and events: 83 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0516:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-335153 |
| 2026-08-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335150 |
| 2026-07-1516:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-304812 |
| 2026-07-0616:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-296200 |
| 2026-07-0616:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-296201 |
| 2026-06-1616:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-272688 |
| 2026-05-0616:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-208921 |
| 2026-05-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208912 |
| 2026-04-2816:30 ET | DEF 14A | Proxy statementPeriod 2026-04-27 | 0001193125-26-187240 |
| 2026-03-1916:06 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-26-115965 |
| 2026-02-2516:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-071775 |
| 2026-02-2516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071516 |
| 2026-01-1216:34 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-010478 |
| 2025-12-2317:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-25-331151 |
| 2025-12-2217:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-328951 |
| 2025-12-1916:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-326889 |
| 2025-11-0516:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-266986 |
| 2025-11-0516:11 ET | 8-K | 2.02 Results of operations | 0001193125-25-266938 |
| 2025-08-1516:30 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001111485-25-000003 |
| 2025-08-0716:23 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105070 |
| 2025-08-0716:10 ET | 8-K | 2.02 Results of operations | 0000950170-25-105027 |
| 2025-08-0416:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-102065 |
| 2025-07-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-094588 |
| 2025-06-0416:15 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-081636 |
| 2025-05-0716:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065683 |
| 2025-05-0716:10 ET | 8-K | 2.02 Results of operations | 0000950170-25-065655 |
| 2025-04-2116:30 ET | DEF 14A | Proxy statementPeriod 2025-04-21 | 0000950170-25-056319 |
| 2025-04-0320:07 ET | 8-K | 2.02 Results of operations | 0000950170-25-049797 |
| 2025-02-2516:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-026681 |
| 2025-02-2516:10 ET | 8-K | 2.02 Results of operations | 0000950170-25-026651 |
| 2025-01-1306:01 ET | 8-K | 2.02 Results of operations | 0000950170-25-004478 |
| 2024-11-0716:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123368 |
| 2024-11-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123322 |
| 2024-08-0516:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-090770 |
| 2024-08-0516:10 ET | 8-K | 2.02 Results of operations | 0000950170-24-090744 |
| 2024-06-0616:15 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-069895 |
| 2024-05-0916:41 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-135328 |
| 2024-05-0616:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053566 |
| 2024-05-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053553 |
| 2024-04-2516:30 ET | DEF 14A | Proxy statementPeriod 2024-04-25 | 0000950170-24-048381 |
| 2024-04-2319:00 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-24-046558 |
| 2024-02-2816:10 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-022073 |
| 2024-02-2816:05 ET | 8-K | 2.02 Results of operations | 0000950170-24-022053 |
| 2024-01-0806:01 ET | 8-K | 2.02 Results of operations | 0000950170-24-002636 |
| 2023-11-0916:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062099 |
| 2023-11-0916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062039 |
| 2023-08-1816:18 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-215970 |
| 2023-08-0716:16 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039081 |
| 2023-08-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039068 |
| 2023-07-0506:04 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0000950170-23-031482 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.